Tuesday - October 27, 2026

AL Amyloidosis Market is Projected to Boom by 2036 Owing to the Advancement of Targeted Therapies and Immunotherapies | DelveInsight

The market dynamics for AL Amyloidosis are witnessing significant transformation driven by the increasing adoption of targeted therapies, advancements in plasma cell-directed treatments, and growing demand for therapies that improve organ function. Additionally, the development of emerging therapies such as … Continue reading →

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Market is Projected to Boom by 2036 Owing to the Launch of Novel Therapies | DelveInsight

The market dynamics for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA-associated Vasculitis) are witnessing steady growth driven by the rising prevalence of autoimmune vasculitis, increasing demand for effective disease management, and growing adoption of targeted therapies. (Albany, New York) – October 27, … Continue reading →

Cocaine Intoxication Market is Projected to Grow by 2034 Owing to the Development of Novel Therapies | DelveInsight

The market dynamics for Cocaine Intoxication are expected to evolve during the forecast period, driven by the increasing burden of cocaine-related emergency visits, the need for effective emergency management, and the lack of approved therapies specifically indicated for cocaine intoxication. … Continue reading →

Hereditary Angioedema Market Size Expected to Climb Sharply by 2036, Fueled by Increasing Diagnosis Rates and Therapeutic Innovation | KalVista Pharma, Intellia Therapeutics, BioMarin Pharma, CSL

The Key Hereditary Angioedema Companies in the market include – KalVista Pharma, CSL Behring, Intellia Therapeutics, ADARx Pharma, Attune Pharma, Ionis Pharmaceuticals, Astria Therapeutics, BioMarin Pharmaceutical, CSL Behring, Pharvaris Netherlands B.V, Takeda, CSL Behring, Shire, and others.   (Albany, New … Continue reading →